Literature DB >> 25670244

Retrocyclins neutralize bacterial toxins by potentiating their unfolding.

Elena Kudryashova1, Stephanie Seveau2, Wuyuan Lu3, Dmitri S Kudryashov1.   

Abstract

Defensins are a class of immune peptides with a broad range of activities against bacterial, fungal and viral pathogens. Besides exerting direct anti-microbial activity via dis-organization of bacterial membranes, defensins are also able to neutralize various unrelated bacterial toxins. Recently, we have demonstrated that in the case of human α- and β-defensins, this later ability is achieved through exploiting toxins' marginal thermodynamic stability, i.e. defensins act as molecular anti-chaperones unfolding toxin molecules and exposing their hydrophobic regions and thus promoting toxin precipitation and inactivation [Kudryashova et al. (2014) Immunity 41, 709-721]. Retrocyclins (RCs) are humanized synthetic θ-defensin peptides that possess unique cyclic structure, differentiating them from α- and β-defensins. Importantly, RCs are more potent against some bacterial and viral pathogens and more stable than their linear counterparts. However, the mechanism of bacterial toxin inactivation by RCs is not known. In the present study, we demonstrate that RCs facilitate unfolding of bacterial toxins. Using differential scanning fluorimetry (DSF), limited proteolysis and collisional quenching of internal tryptophan fluorescence, we show that hydrophobic regions of toxins normally buried in the molecule interior become more exposed to solvents and accessible to proteolytic cleavage in the presence of RCs. The RC-induced unfolding of toxins led to their precipitation and abrogated activity. Toxin inactivation by RCs was strongly diminished under reducing conditions, but preserved at physiological salt and serum concentrations. Therefore, despite significant structural diversity, α-, β- and θ-defensins employ similar mechanisms of toxin inactivation, which may be shared by anti-microbial peptides from other families.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25670244      PMCID: PMC5201114          DOI: 10.1042/BJ20150049

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.766


  55 in total

1.  The Actin cross-linking domain of the Vibrio cholerae RTX toxin directly catalyzes the covalent cross-linking of actin.

Authors:  Christina L Cordero; Dmitry S Kudryashov; Emil Reisler; Karla J Fullner Satchell
Journal:  J Biol Chem       Date:  2006-09-05       Impact factor: 5.157

2.  Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences.

Authors:  Chun Kim; Nadesan Gajendran; Hans-Willi Mittrücker; Matthias Weiwad; Young-Hwa Song; Robert Hurwitz; Matthias Wilmanns; Gunter Fischer; Stefan H E Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-16       Impact factor: 11.205

3.  θ-Defensins: cyclic peptides with endless potential.

Authors:  Robert I Lehrer; Alex M Cole; Michael E Selsted
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

4.  RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates.

Authors:  Sherry M Owen; Donna L Rudolph; Wei Wang; Alexander M Cole; Alan J Waring; Renu B Lal; Robert I Lehrer
Journal:  AIDS Res Hum Retroviruses       Date:  2004-11       Impact factor: 2.205

5.  Characterization of membrane translocation by anthrax protective antigen.

Authors:  J Wesche; J L Elliott; P O Falnes; S Olsnes; R J Collier
Journal:  Biochemistry       Date:  1998-11-10       Impact factor: 3.162

6.  Focal targeting by human β-defensin 2 disrupts localized virulence factor assembly sites in Enterococcus faecalis.

Authors:  Kumaravel Kandaswamy; Tze Horng Liew; Charles Y Wang; Emily Huston-Warren; Ulf Meyer-Hoffert; Kjell Hultenby; Jens M Schröder; Michael G Caparon; Staffan Normark; Birgitta Henriques-Normark; Scott J Hultgren; Kimberly A Kline
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

7.  Human alpha-defensins inhibit Clostridium difficile toxin B.

Authors:  Torsten Giesemann; Gregor Guttenberg; Klaus Aktories
Journal:  Gastroenterology       Date:  2008-03-10       Impact factor: 22.682

8.  Evolution of primate theta-defensins: a serpentine path to a sweet tooth.

Authors:  Tung X Nguyen; Alex M Cole; Robert I Lehrer
Journal:  Peptides       Date:  2003-11       Impact factor: 3.750

9.  Retrocyclin inhibits Gardnerella vaginalis biofilm formation and toxin activity.

Authors:  Thomas A Hooven; Tara M Randis; Saul R Hymes; Ryan Rampersaud; Adam J Ratner
Journal:  J Antimicrob Chemother       Date:  2012-07-31       Impact factor: 5.790

10.  Identification, purification and characterization of laterosporulin, a novel bacteriocin produced by Brevibacillus sp. strain GI-9.

Authors:  Pradip Kumar Singh; Vikas Sharma; Prabhu B Patil; Suresh Korpole
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

View more
  7 in total

1.  Full Sequence Amino Acid Scanning of θ-Defensin RTD-1 Yields a Potent Anthrax Lethal Factor Protease Inhibitor.

Authors:  Yilong Li; Andrew Gould; Teshome Aboye; Tao Bi; Leonard Breindel; Alexander Shekhtman; Julio A Camarero
Journal:  J Med Chem       Date:  2017-02-14       Impact factor: 7.446

2.  A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii.

Authors:  Cheng Wang; Gaomei Zhao; Song Wang; Yin Chen; Yali Gong; Shilei Chen; Yang Xu; Mengjia Hu; Xinmiao Wang; Hao Zeng; Aiping Wang; Dengqun Liu; Yongping Su; Tianmin Cheng; Fang Chen; Junping Wang
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

Review 3.  Targeting and inactivation of bacterial toxins by human defensins.

Authors:  Elena Kudryashova; Stephanie M Seveau; Dmitri S Kudryashov
Journal:  Biol Chem       Date:  2017-09-26       Impact factor: 4.700

4.  Thermodynamic instability of viral proteins is a pathogen-associated molecular pattern targeted by human defensins.

Authors:  Elena Kudryashova; Pratibha C Koneru; Mamuka Kvaratskhelia; Adam A Strömstedt; Wuyuan Lu; Dmitri S Kudryashov
Journal:  Sci Rep       Date:  2016-09-01       Impact factor: 4.379

5.  Defensins versus pathogens: an unfolding story.

Authors:  Elena Kudryashova; Wuyuan Lu; Dmitri S Kudryashov
Journal:  Oncotarget       Date:  2015-10-06

Review 6.  Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition.

Authors:  Osmel Fleitas Martínez; Marlon Henrique Cardoso; Suzana Meira Ribeiro; Octavio Luiz Franco
Journal:  Front Cell Infect Microbiol       Date:  2019-04-02       Impact factor: 5.293

7.  Rounding Out the Understanding of ACD Toxicity with the Discovery of Cyclic Forms of Actin Oligomers.

Authors:  Harper Smith; Nick Pinkerton; David B Heisler; Elena Kudryashova; Aaron R Hall; Kelly R Karch; Andrew Norris; Vicki Wysocki; Marcos Sotomayor; Emil Reisler; Dimitrios Vavylonis; Dmitri S Kudryashov
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.